Absci Corporation (ABSI) vs Xencor, Inc. (XNCR)
Absci Corporation and Xencor, Inc. are both Biotechnology companies. Absci Corporation and Xencor, Inc. are of similar size ($1.8B and $1.8B). Xencor, Inc. grew revenue faster over the last twelve months: −28.6% against −62.3%. Xencor, Inc. has the higher net margin (−155.6% vs −7,756.4%) and the lower return on invested capital (−288.7% vs −174.7%). Across the 17 metrics below, Xencor, Inc. leads on 12 and Absci Corporation on 5.
Valuation
Profitability
| Metric | ABSI | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (8,084.50%) | (205.84%) | 0.00% |
| Net margin | (7,756.37%) | (155.59%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (198.42%) | 0.00% |
| Return on equity | (57.72%) | (29.07%) | (57.72%) |
| Return on assets | (50.57%) | (20.36%) | (49.22%) |
| Return on invested capital | (174.74%) | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack